VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Valion Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.16−0.01 (-0.85%)
Close on Oct 19, 2026
- Market cap
- $3.92M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 31, 2026 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Mar 7, 2025 | 1-for-17 reverse | Earlier per-share figures multiplied by 17 |
| Mar 7, 2025 | 1-for-17 reverse | Earlier per-share figures multiplied by 17 |
| Aug 23, 2023 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Aug 23, 2023 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |